These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31323052)

  • 21. Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors.
    Loyau J; Malinge P; Daubeuf B; Shang L; Elson G; Kosco-Vilbois M; Fischer N; Rousseau F
    MAbs; 2014; 6(6):1621-30. PubMed ID: 25484053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural analysis of Fc/FcγR complexes: a blueprint for antibody design.
    Caaveiro JM; Kiyoshi M; Tsumoto K
    Immunol Rev; 2015 Nov; 268(1):201-21. PubMed ID: 26497522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural mechanism of high affinity FcγRI recognition of immunoglobulin G.
    Lu J; Sun PD
    Immunol Rev; 2015 Nov; 268(1):192-200. PubMed ID: 26497521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The high-affinity receptor for IgG, FcγRI, of humans and non-human primates.
    Chenoweth AM; Trist HM; Tan PS; Wines BD; Hogarth PM
    Immunol Rev; 2015 Nov; 268(1):175-91. PubMed ID: 26497520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with FcγRIIIa and Other Fcγ Receptors.
    Isoda Y; Yagi H; Satoh T; Shibata-Koyama M; Masuda K; Satoh M; Kato K; Iida S
    PLoS One; 2015; 10(10):e0140120. PubMed ID: 26444434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterizing the effect of multiple Fc glycan attributes on the effector functions and FcγRIIIa receptor binding activity of an IgG1 antibody.
    Pace D; Lewis N; Wu T; Gillespie R; Leiske D; Velayudhan J; Rohrbach A; Connell-Crowley L
    Biotechnol Prog; 2016 Sep; 32(5):1181-1192. PubMed ID: 27160519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody Fucosylation Lowers the FcγRIIIa/CD16a Affinity by Limiting the Conformations Sampled by the N162-Glycan.
    Falconer DJ; Subedi GP; Marcella AM; Barb AW
    ACS Chem Biol; 2018 Aug; 13(8):2179-2189. PubMed ID: 30016589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Species specificity in the binding of IgG to macrophages.
    Leslie RG; Niemetz AH
    Immunology; 1979 Aug; 37(4):835-40. PubMed ID: 500129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specificity of staphylococcal superantigen-like protein 10 toward the human IgG1 Fc domain.
    Patel D; Wines BD; Langley RJ; Fraser JD
    J Immunol; 2010 Jun; 184(11):6283-92. PubMed ID: 20427768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc.
    Idusogie EE; Presta LG; Gazzano-Santoro H; Totpal K; Wong PY; Ultsch M; Meng YG; Mulkerrin MG
    J Immunol; 2000 Apr; 164(8):4178-84. PubMed ID: 10754313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chimeric rabbit/human Fab and IgG specific for members of the Nogo-66 receptor family selected for species cross-reactivity with an improved phage display vector.
    Hofer T; Tangkeangsirisin W; Kennedy MG; Mage RG; Raiker SJ; Venkatesh K; Lee H; Giger RJ; Rader C
    J Immunol Methods; 2007 Jan; 318(1-2):75-87. PubMed ID: 17140598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity.
    Shields RL; Lai J; Keck R; O'Connell LY; Hong K; Meng YG; Weikert SH; Presta LG
    J Biol Chem; 2002 Jul; 277(30):26733-40. PubMed ID: 11986321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.
    Wright A; Morrison SL
    J Immunol; 1998 Apr; 160(7):3393-402. PubMed ID: 9531299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
    Vafa O; Gilliland GL; Brezski RJ; Strake B; Wilkinson T; Lacy ER; Scallon B; Teplyakov A; Malia TJ; Strohl WR
    Methods; 2014 Jan; 65(1):114-26. PubMed ID: 23872058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
    Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
    Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biophysical Characterization of the Contribution of the Fab Region to the IgG-FcγRIIIa Interaction.
    Kosuge H; Nagatoishi S; Kiyoshi M; Ishii-Watabe A; Terao Y; Ide T; Tsumoto K
    Biochemistry; 2023 Jan; 62(2):262-269. PubMed ID: 35605982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
    Borrok MJ; Luheshi NM; Beyaz N; Davies GC; Legg JW; Wu H; Dall'Acqua WF; Tsui P
    MAbs; 2015; 7(4):743-51. PubMed ID: 25970007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector Functions.
    Grevys A; Bern M; Foss S; Bratlie DB; Moen A; Gunnarsen KS; Aase A; Michaelsen TE; Sandlie I; Andersen JT
    J Immunol; 2015 Jun; 194(11):5497-508. PubMed ID: 25904551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII.
    Davies J; Jiang L; Pan LZ; LaBarre MJ; Anderson D; Reff M
    Biotechnol Bioeng; 2001 Aug; 74(4):288-94. PubMed ID: 11410853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant soluble human Fcgamma receptor I with picomolar affinity for immunoglobulin G.
    Paetz A; Sack M; Thepen T; Tur MK; Bruell D; Finnern R; Fischer R; Barth S
    Biochem Biophys Res Commun; 2005 Dec; 338(4):1811-7. PubMed ID: 16289041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.